am 580 and alitretinoin

am 580 has been researched along with alitretinoin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, Y; Himi, T; Kagechika, H; Kawachi, E; Shudo, K1
Bradley, KA; Damoiseaux, R; Gillespie, EJ; Huang, J; Manchester, M; Rogers, J; Sanchez, AM; Saxe, JP; Thomas, D1
Commes, T; Defacque, H; Marti, J; Piquemal, D; Rochette-Egly, C; Sévilla, C1
Bernardon, JM; Fésüs, L; Karászi, E; Michel, S; Reichert, U; Szondy, Z; Tóth, R1
Garattini, E; Gianni, M; Mologni, L; Ponzanelli, I; Rambaldi, A; Reichert, U; Terao, M1
Adam-Stitah, S; Haxsen, V; Ritz, E; Wagner, J1
Kanaya, S; Kunii, R; Nemoto, E; Shibuya, N; Shimauchi, H1
Ross, AC; Wu, L1

Other Studies

8 other study(ies) available for am 580 and alitretinoin

ArticleYear
Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Amides; Binding Sites; Cell Differentiation; Humans; Leukemia, Promyelocytic, Acute; Methylation; Molecular Structure; Retinoids; Structure-Activity Relationship

1988
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amiodarone; Animals; Anthrax; Antigens, Bacterial; Bacterial Toxins; Bepridil; Cell Line; Cell Survival; Chloroquine; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Macrophages, Peritoneal; Male; Mice; Molecular Structure; Rats; Rats, Inbred F344; Time Factors

2007
Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Leukemia, 1997, Volume: 11, Issue:2

    Topics: Alitretinoin; Animals; Benzoates; Bexarotene; Cell Differentiation; Chromans; COS Cells; HL-60 Cells; Humans; Leukemia, Monocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Molecular Structure; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Transcription Factors; Transfection; Tretinoin; Tumor Cells, Cultured; Vitamin D

1997
Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
    The Biochemical journal, 1998, May-01, Volume: 331 ( Pt 3)

    Topics: Alitretinoin; Animals; Antibodies; Antigens, CD; Apoptosis; Benzoates; Cells, Cultured; DNA Fragmentation; Male; Mice; Mice, Inbred Strains; Phorbol 12,13-Dibutyrate; Protein Binding; Receptors, Antigen, T-Cell; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Tetrahydronaphthalenes; Thymus Gland; Transcription Factors; Tretinoin

1998
Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases.
    Cell death and differentiation, 2000, Volume: 7, Issue:5

    Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Benzoates; Caspases; Cell Differentiation; Cell Division; Enzyme Activation; Gene Expression; Humans; Leukemia, Promyelocytic, Acute; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Tetrahydronaphthalenes; Transcription Factors; Tretinoin; Tumor Cells, Cultured

2000
Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
    Circulation research, 2001, Mar-30, Volume: 88, Issue:6

    Topics: Alitretinoin; Angiotensin II; Animals; Benzoates; Cell Division; Cells, Cultured; COS Cells; DNA; Dose-Response Relationship, Drug; Gene Expression; Gene Expression Regulation; Luciferases; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; RNA, Messenger; Tetrahydronaphthalenes; Transcription Factor AP-1; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tretinoin

2001
Retinoic acid is a potential negative regulator for differentiation of human periodontal ligament cells.
    Journal of periodontal research, 2005, Volume: 40, Issue:6

    Topics: Alitretinoin; Alkaline Phosphatase; Ascorbic Acid; Benzoates; Cell Differentiation; Cells, Cultured; Cementogenesis; Dexamethasone; Enzyme Inhibitors; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Glycerophosphates; Humans; Isotretinoin; Periodontal Ligament; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Tetrahydronaphthalenes; Time Factors; Transcription Factors; Tretinoin

2005
Acidic retinoids synergize with vitamin A to enhance retinol uptake and STRA6, LRAT, and CYP26B1 expression in neonatal lung.
    Journal of lipid research, 2010, Volume: 51, Issue:2

    Topics: Absorption; Acyltransferases; Alitretinoin; Animals; Animals, Newborn; Benzoates; Biological Transport; Cytochrome P-450 Enzyme System; Drug Synergism; Esters; Gene Expression Regulation; Homeostasis; Hydrogen-Ion Concentration; Lung; Membrane Proteins; Rats; Rats, Sprague-Dawley; Retinoic Acid 4-Hydroxylase; Retinoids; Tetrahydronaphthalenes; Time Factors; Tretinoin; Vitamin A

2010
chemdatabank.com